Provenance record

Single-nucleus transcriptome-wide association study of human brain disorders

Nature (tier 1, academic) 2026-09-23T00:00:00.000Z Original ↗

Discourse valence
-16
Mixed or uncertain
confidence 58% · 5 items · range -100 to +10
Adverse readingFavourable reading
Consensus of 5 models from different labs. Spread 110 points, agreement low.
Biological and chemical upliftMedicine and healthScientific acceleration
Excerpt as ingested

Nature, Published online: 23 September 2026; doi:10.1038/s41586-026-10836-6 Single-nucleus transcriptomics across diverse populations is used to explore how genetic risk for brain disorders affects specific cell types, revealing previously hidden gene–trait associations and conserved, cell-type-specific mechanisms.

Every model that read this

ModelProviderStageScoreConf.LatencyPromptWhen
Llama 3.3 70BMetaanalysis 0 20%2949ms v1.0.0 / m1.0.1 2026-09-23 21:18
GPT-4.1 miniOpenAIconsensus +10 70%2119ms v1.0.0 / m1.0.1 2026-09-23 21:21
Claude Sonnet 5Anthropicconsensus +5 30%5681ms v1.0.0 / m1.0.1 2026-09-23 21:21
Gemini 2.5 FlashGoogleconsensus -100 90%1764ms v1.0.0 / m1.0.1 2026-09-23 21:21
Mistral Small 3.1 24BMistral AIconsensus +5 80%12645ms v1.0.0 / m1.0.1 2026-09-23 21:21
Llama 3.3 70B · reading

No direct AI implication

evidence: speculative horizon: n/a
GPT-4.1 mini · reading

The study advances understanding of genetic risk for brain disorders at the cell-type level, which could enable improved treatments. However, it is basic research without immediate societal impact or clear benefits or harms currently evident.

evidence: primary horizon: medium capability 30 societal 20 existential 0 economic 15
Claude Sonnet 5 · reading

This is a basic biomedical research study using transcriptomics, not directly about AI's societal implications. The mention of AI-adjacent computational methods is implicit at best; the abstract describes genetic and cellular biology findings with no stated connection to AI systems or their societal effects.

evidence: reported horizon: n/a
Gemini 2.5 Flash · reading

The study uses advanced transcriptomics to uncover genetic links to brain disorders at a cellular level. This deepens understanding of diseases like Alzheimer's or Parkinson's, potentially leading to better diagnostics and treatments. The direct benefit to human health is significant and clearly implied.

evidence: reported horizon: n/a
Mistral Small 3.1 24B · reading

The article discusses a scientific study using AI to analyze genetic data. It does not discuss societal implications. The study's findings could lead to better understanding and treatment of brain disorders, but the article does not speculate on this.

evidence: primary horizon: n/a existential 0

Evidence extracted

The chain
SOURCE     Nature (tier 1)
   ↓
DOCUMENT   d983be22-e2f7-47fd-a188-442030fab8a1
           https://nature.com/articles/s41586-026-10836-6
   ↓
EVIDENCE   1 extracted excerpt
   ↓
MODEL RUN  5 runs, methodology 1.0.1
   ↓
SCORE      -16  (Mixed or uncertain)
   ↓
CONFIDENCE 58%